Sanara MedTech Inc.
SMTI
$23.17
-$0.47-1.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 107.51M | 103.14M | 101.90M | 97.24M | 91.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.51M | 103.14M | 101.90M | 97.24M | 91.57M |
| Cost of Revenue | 7.61M | 7.52M | 7.90M | 8.01M | 8.08M |
| Gross Profit | 99.90M | 95.62M | 94.01M | 89.23M | 83.49M |
| SG&A Expenses | 83.39M | 80.64M | 80.78M | 78.32M | 75.73M |
| Depreciation & Amortization | 2.98M | 3.09M | 2.60M | 2.69M | 2.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.06M | 96.52M | 95.40M | 92.90M | 90.10M |
| Operating Income | 8.45M | 6.63M | 6.50M | 4.34M | 1.47M |
| Income Before Tax | -1.89M | -2.91M | -869.80K | -1.88M | -3.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.89 | -2.91 | -0.87 | -1.88 | -3.40 |
| Earnings from Discontinued Operations | -31.69M | -34.66M | -36.63M | -8.06M | -8.06M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.60K | 5.40K | 5.20K | 5.90K | 27.10K |
| Net Income | -33.58M | -37.56M | -37.49M | -9.94M | -11.43M |
| EBIT | 8.45M | 6.63M | 6.50M | 4.34M | 1.47M |
| EBITDA | 11.48M | 9.77M | 9.16M | 7.44M | 4.56M |
| EPS Basic | -3.89 | -4.35 | -4.34 | -1.16 | -1.34 |
| Normalized Basic EPS | 0.00 | -0.08 | -0.03 | -0.10 | -0.21 |
| EPS Diluted | -3.78 | -4.24 | -4.23 | -1.16 | -1.34 |
| Normalized Diluted EPS | -0.01 | -0.08 | -0.03 | -0.10 | -0.21 |
| Average Basic Shares Outstanding | 34.44M | 34.30M | 34.36M | 34.23M | 34.09M |
| Average Diluted Shares Outstanding | 35.01M | 34.60M | 34.66M | 34.23M | 34.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |